TCR tracking in liver cancer, lung cancer, and colorectal cancer has shown that Mki67-positive CD8+ T cells share the same TCR sequence (paired α and β chains) with those identified exhausted effector T cells with anti-tumor effects, suggesting that they have the same origin but different states[29]. This evidence concerns the gene CD8A and liver cancer.